Completed OBSERVATIONAL NCT01817946

Myotubular Myopathy Genetic Testing Study

Sponsor: Boston Children's Hospital

Updated 12 times since 2017 Last updated: Mar 5, 2018 Started: Mar 31, 2013 Primary completion: Mar 31, 2017 Completion: Mar 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Myotubular Myopathy and is currently completed. Boston Children's Hospital leads this study, which shows 12 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

12 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 7 earlier versions

Sep 2020 — Nov 2020 [monthly]

Completed
Jun 2018 — Sep 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Mar 2018 — Apr 2018 [monthly]

Completed NA

Status: Recruiting → Completed
Aug 2017 — Mar 2018 [monthly]

Recruiting NA
Jan 2017 — Aug 2017 [monthly]

Recruiting NA

First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Boston Children's Hospital
Congenital Muscle Disease International Registr
Cure CMD
University of Chicago
Valerion Therapeutics, LLC

Data source: Cure CMD

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Torrance, United States